Hangzhou, Shanghai and Sydney bring 325,000 sq. ft. of dedicated space to market
Continuing its years-long expansion of logistics resources globally, UPS Healthcare Logistics has announced the opening of three new facilities in the Asia-Pacific region, bringing the total number of dedicated healthcare-logistics facilities to 36. These new facilities complement the existing center in Singapore, opened last year. Collectively, the facilities serve both international and regional distribution needs for pharmaceutical, biotech and medical device manufacturers.
Hangzhou, with 22,000 sq. m. (204,000 sq. ft.) of space is primarily for pharma manufacturers locating in the region.
Shanghai, with 7,575 sq. m. (70,400 sq. ft.) of space in the Waigaoqiao Free Trade Zone, is adjacent to the UPS International Air Hub, and will primarily serve med device markets.
Sydney, with 5,388 sq. m. (50,000 sq. ft.), mostly to serve regional healthcare needs.
“Asia is our fastest-growing market for healthcare and we are seeing increased activity in the region, especially in China, where a growing demand for acute and chronic care has driven the need for reliable, flexible and compliant supply chains to serve a highly dynamic market,” said Bill Hook, VP, global strategy, UPS Healthcare Logistics.
Meanwhile, UPS’ corporate activity in Europe is still in a holding pattern: The company is addressing a “statement of objections” from the European Commission over its proposed acquisition of express-delivery firm TNT Express (Hoofdorp, Netherlands). UPS still expects to close the transaction in early 2013.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.